Number of isolates tested for extended-spectrum cephalosporins in Canada
Canada: Number of isolates tested for extended-spectrum cephalosporins was 3,122 in 2018. ▲ Rising
Latest (2018)
3,122
Change on year
up 6.3%
World rank
3rd
of 51 countries
All-time high
4,538
in 2016
All-time low
2,936
in 2017
Years of data
10
2009–2018
Number of isolates tested for extended-spectrum cephalosporins in Canada, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for number of isolates tested for extended-spectrum cephalosporins in Canada is 3,122, measured in 2018.
Compared with earlier readings it is up 6.3% on the previous year and up 0.5% over ten years.
Over the whole period, number of isolates tested for extended-spectrum cephalosporins in Canada peaked at 4,538 in 2016 and was at its lowest, 2,936, in 2017.
Canada ranks 3rd of 51 countries on this measure, in the top 10%.
Number of isolates tested for extended-spectrum cephalosporins in Canada, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 3,106 | — |
| 2010 | 2,970 | -4.4% |
| 2011 | 3,360 | +13.1% |
| 2012 | 3,036 | -9.6% |
| 2013 | 3,195 | +5.2% |
| 2014 | 3,106 | -2.8% |
| 2015 | 4,190 | +34.9% |
| 2016 | 4,538 | +8.3% |
| 2017 | 2,936 | -35.3% |
| 2018 | 3,122 | +6.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3,106 | 3,106 | 3,106 | 1 |
| 2010s | 3,384 | 2,936 | 4,538 | 9 |
Countries ranked near Canada
More health data for Canada
- Un projection of annual infant deaths, annual growth rate -1.79 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3588 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,083 deaths per 1,000 people (2090)
- Number of infants who die before age 1 385 deaths (2100)
- Population ages 15-19, male, annual growth rate 1.3 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0279 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.2775 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0298 units per person (2025)
Frequently asked questions
- What is number of isolates tested for extended-spectrum cephalosporins in Canada?
- Number of isolates tested for extended-spectrum cephalosporins in Canada was 3,122 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest number of isolates tested for extended-spectrum cephalosporins recorded in Canada?
- The highest recorded value was 4,538 in 2016.
- What is the lowest number of isolates tested for extended-spectrum cephalosporins recorded in Canada?
- The lowest recorded value was 2,936 in 2017.
- How does Canada rank for number of isolates tested for extended-spectrum cephalosporins?
- Canada ranks 3rd out of 51 countries with data for 2018.
- Is number of isolates tested for extended-spectrum cephalosporins rising or falling in Canada?
- Over the last ten years it is up 0.5%. The long-run trend across the full record is rising.
- Where does this Canada data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Number of isolates tested for extended-spectrum cephalosporins. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).